Concourse Financial Group Securities, Inc. Astrazeneca PLC Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 25,301 shares of AZN stock, worth $1.68 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

25,301

Previous 21,043 20.23%

Holding current value

$1.68 Million

Previous $1.64 Million 20.11%

% of portfolio

0.12%

Previous 0.11%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$76.67 - $87.62 $326,460 - $373,085	4,258 Added 20.23%	25,301 $1.97 Million
Q2 2024 Jul 23, 2024	BUY	$66.81 - $80.83 $87,387 - $105,725	1,308 Added 6.63%	21,043 $1.64 Million
Q1 2024 Apr 30, 2024	BUY	$61.03 - $69.57 $55,903 - $63,726	916 Added 4.87%	19,735 $1.34 Million
Q4 2023 Feb 07, 2024	BUY	$61.89 - $69.28 $437,129 - $489,324	7,063 Added 60.08%	18,819 $1.27 Million
Q3 2023 Oct 25, 2023	SELL	$64.85 - $71.7 $19,844 - $21,940	-306 Reduced 2.54%	11,756 $796,000
Q2 2023 Aug 10, 2023	BUY	$69.91 - $75.81 $58,235 - $63,149	833 Added 7.42%	12,062 $863,000
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $631,310 - $715,785	9,997 Added 811.44%	11,229 $779,000
Q4 2022 Jan 30, 2023	BUY	$54.21 - $70.44 $542 - $704	10 Added 0.82%	1,232 $0
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $848 - $2,172	16 Added 1.33%	1,222 $67,000
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $20,918 - $25,112	-353 Reduced 22.64%	1,206 $80,000
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $144,760 - $174,377	-2,598 Reduced 62.5%	1,559 $104,000
Q4 2021 Feb 07, 2022	BUY	$54.02 - $63.83 $4,105 - $4,851	76 Added 1.86%	4,157 $242,000
Q3 2021 Nov 09, 2021	BUY	$55.56 - $60.79 $12,334 - $13,495	222 Added 5.75%	4,081 $245,000
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $8,134 - $10,110	-168 Reduced 4.17%	3,859 $231,000
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $147,610 - $170,397	3,130 Added 348.94%	4,027 $200,000
Q4 2020 Feb 02, 2021	SELL	$48.52 - $58.02 $3,153 - $3,771	-65 Reduced 6.76%	897 $45,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $1,804 - $2,077	34 Added 3.66%	962 $53,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $2,284 - $2,931	53 Added 6.06%	928 $49,000
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $33,066 - $44,913	875 New	875 $39,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	SELL	$37.28 - $41.68 $73,106 - $81,734	-1,961 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $7,914 - $9,593	223 Added 12.83%	1,961 $79,000
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $20,641 - $23,234	560 Added 47.54%	1,738 $66,000
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $40,947 - $46,790	1,178 New	1,178 $47,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Astrazeneca PLC Transaction History